Vascular dysfunction and increased cardiovascular risk in hypospadias.


Journal

European heart journal
ISSN: 1522-9645
Titre abrégé: Eur Heart J
Pays: England
ID NLM: 8006263

Informations de publication

Date de publication:
14 05 2022
Historique:
received: 18 06 2021
revised: 30 12 2021
accepted: 15 02 2022
entrez: 14 5 2022
pubmed: 15 5 2022
medline: 20 5 2022
Statut: ppublish

Résumé

Hypogonadism is associated with cardiovascular disease. However, the cardiovascular impact of hypogonadism during development is unknown. Using hypospadias as a surrogate of hypogonadism, we investigated whether hypospadias is associated with vascular dysfunction and is a risk factor for cardiovascular disease. Our human study spanned molecular mechanistic to epidemiological investigations. Clinical vascular phenotyping was performed in adolescents with hypospadias and controls. Small subcutaneous arteries from penile skin from boys undergoing hypospadias repair and controls were isolated and functional studies were assessed by myography. Vascular smooth muscle cells were used to assess: Rho kinase, reactive oxygen species (ROS), nitric oxide synthase/nitric oxide, and DNA damage. Systemic oxidative stress was assessed in plasma and urine. Hospital episode data compared men with a history of hypospadias vs. controls. In adolescents with hypospadias, systolic blood pressure (P = 0.005), pulse pressure (P = 0.03), and carotid intima-media thickness standard deviation scores (P = 0.01) were increased. Arteries from boys with hypospadias demonstrated increased U46619-induced vasoconstriction (P = 0.009) and reduced acetylcholine-induced endothelium-dependent (P < 0.0001) and sodium nitroprusside-induced endothelium-independent vasorelaxation (P < 0.0001). Men born with hypospadias were at increased risk of arrhythmia [odds ratio (OR) 2.8, 95% confidence interval (CI) 1.4-5.6, P = 0.003]; hypertension (OR 4.2, 95% CI 1.5-11.9, P = 0.04); and heart failure (OR 1.9, 95% CI 1.7-114.3, P = 0.02). Hypospadias is associated with vascular dysfunction and predisposes to hypertension and cardiovascular disease in adulthood. Underlying mechanisms involve perturbed Rho kinase- and Nox5/ROS-dependent signalling. Our novel findings delineate molecular mechanisms of vascular injury in hypogonadism, and identify hypospadias as a cardiovascular risk factor in males.

Identifiants

pubmed: 35567552
pii: 6585849
doi: 10.1093/eurheartj/ehac112
pmc: PMC9113289
doi:

Substances chimiques

Reactive Oxygen Species 0
Nitric Oxide 31C4KY9ESH
rho-Associated Kinases EC 2.7.11.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1832-1845

Subventions

Organisme : Chief Scientist Office
ID : PCL/21/05
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RE/13/5/30177
Pays : United Kingdom
Organisme : British Heart Foundation
ID : RE/18/6/34217
Pays : United Kingdom
Organisme : British Heart Foundation
ID : CH/12/4/29762
Pays : United Kingdom

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of European Society of Cardiology.

Références

Mayo Clin Proc. 2015 Feb;90(2):224-51
pubmed: 25636998
Clin Dysmorphol. 2019 Jul;28(3):114-119
pubmed: 30921090
Sex Dev. 2019;13(2):67-73
pubmed: 30913557
J Neurochem. 2016 Jan;136(1):106-17
pubmed: 26385432
Biochem Biophys Res Commun. 2012 Aug 3;424(3):538-43
pubmed: 22771325
J Hypertens. 2016 Oct;34(10):1887-920
pubmed: 27467768
PLoS Biol. 2019 Feb 14;17(2):e3000002
pubmed: 30763313
Hypertension. 2016 Nov;68(5):1132-1138
pubmed: 27733585
J Cardiovasc Pharmacol Ther. 2017 Sep;22(5):414-433
pubmed: 28421834
Horm Metab Res. 2004 Apr;36(4):197-202
pubmed: 15114516
Circulation. 2004 May 4;109(17):2074-9
pubmed: 15096452
Hypertension. 2013 Sep;62(3):550-6
pubmed: 23817494
Circulation. 2018 Jul 3;138(1):110-113
pubmed: 29967236
Methods Mol Biol. 2017;1527:349-354
pubmed: 28116729
Eur Heart J. 2021 Sep 7;42(34):3227-3337
pubmed: 34458905
J Am Coll Cardiol. 2012 Dec 25;60(25):2631-9
pubmed: 23083789
Endocr Pract. 2002 Nov-Dec;8(6):440-56
pubmed: 15260010
J Clin Endocrinol Metab. 2011 Dec;96(12):E1953-62
pubmed: 21937623
Expert Rev Pharmacoecon Outcomes Res. 2005 Jun;5(3):353-64
pubmed: 19807604
Hypertension. 2018 Jul;72(1):235-246
pubmed: 29844144
J Clin Endocrinol Metab. 2014 Feb;99(2):E348-55
pubmed: 24302751
J Pediatr Urol. 2017 Feb;13(1):57.e1-57.e5
pubmed: 27670783
Hypertension. 2010 Aug;56(2):217-24
pubmed: 20566959
Circ Res. 2012 Apr 27;110(9):1217-25
pubmed: 22456182
Clin Sci (Lond). 2015 Jul;129(1):39-48
pubmed: 25700020
J Endocrinol. 2013 May 07;217(3):R47-71
pubmed: 23549841
Stroke. 2009 Apr;40(4):1519-21
pubmed: 19265060
Cardiovasc Res. 2006 Dec 1;72(3):456-63
pubmed: 17049502
Eur J Endocrinol. 2011 Nov;165(5):687-701
pubmed: 21852391
Hum Reprod. 2017 Oct 1;32(10):2130-2137
pubmed: 28938747
Am J Physiol Regul Integr Comp Physiol. 2003 Jun;284(6):R1572-9
pubmed: 12573976
Antioxid Redox Signal. 2014 Jan 1;20(1):164-82
pubmed: 23600794
J Cardiovasc Pharmacol. 2006 Sep;48(3):103-9
pubmed: 17031263
Endocr Metab Immune Disord Drug Targets. 2013 Mar;13(1):92-9
pubmed: 23369141
Eur J Clin Invest. 1994 Feb;24 Suppl 1:50-2
pubmed: 8013532
Front Physiol. 2012 Apr 10;3:89
pubmed: 22514541
Int J Androl. 2010 Feb;33(1):e132-8
pubmed: 19747201
Expert Rev Endocrinol Metab. 2020 Sep;15(5):355-362
pubmed: 33076711
Toxicol Sci. 2001 Aug;62(2):236-49
pubmed: 11452136
Mol Med Rep. 2011 Nov-Dec;4(6):1183-8
pubmed: 21785825
Hypertens Res. 2007 Nov;30(11):1029-34
pubmed: 18250551
JCI Insight. 2019 Dec 5;4(23):
pubmed: 31647781
J Sex Med. 2011 Mar;8(3):675-87
pubmed: 21054792
J Clin Invest. 2008 Apr;118(4):1479-90
pubmed: 18340380
Vascul Pharmacol. 2018 Nov;110:71-74
pubmed: 30076925
J Sex Med. 2007 May;4(3):620-632
pubmed: 17498101
Eur Heart J. 2018 Sep 1;39(33):3021-3104
pubmed: 30165516
J Sex Med. 2018 May;15(5):654-661
pubmed: 29606625
Med Sci Sports Exerc. 2008 Apr;40(4):767-72
pubmed: 18317366
Am J Physiol Heart Circ Physiol. 2014 Jun 1;306(11):H1485-94
pubmed: 24658017
J Am Heart Assoc. 2018 Jun 15;7(12):
pubmed: 29907654
J Hypertens. 2001 May;19(5):921-30
pubmed: 11393676
Cardiovasc Res. 2018 Mar 15;114(4):529-539
pubmed: 29394331
Proc Natl Acad Sci U S A. 1989 Dec;86(24):9697-701
pubmed: 2602371
Andrologia. 2019 Feb;51(1):e13173
pubmed: 30311248
Circulation. 2013 Jul 16;128(3):217-24
pubmed: 23780579
Clin Sci (Lond). 2017 Jul 1;131(13):1405-1418
pubmed: 28645930
J Pharmacol Sci. 2015 Oct;129(2):83-94
pubmed: 26499181
Reprod Biol Endocrinol. 2019 Feb 16;17(1):24
pubmed: 30771790
Int J Impot Res. 2012 May-Jun;24(3):110-3
pubmed: 22258063

Auteurs

Angela K Lucas-Herald (AK)

Institute of Cardiovascular and Medical Sciences, British Heart Foundation Centre for Research Excellence, University of Glasgow, 126 University Avenue, Glasgow G12 8TA, UK.
Developmental Endocrinology Research Group, School of Medicine, Dentistry and Nursing, University of Glasgow, Royal Hospital for Children, 1345 Govan Road, Glasgow G45 8TF, UK.

Augusto C Montezano (AC)

Institute of Cardiovascular and Medical Sciences, British Heart Foundation Centre for Research Excellence, University of Glasgow, 126 University Avenue, Glasgow G12 8TA, UK.

Rheure Alves-Lopes (R)

Institute of Cardiovascular and Medical Sciences, British Heart Foundation Centre for Research Excellence, University of Glasgow, 126 University Avenue, Glasgow G12 8TA, UK.

Laura Haddow (L)

Institute of Cardiovascular and Medical Sciences, British Heart Foundation Centre for Research Excellence, University of Glasgow, 126 University Avenue, Glasgow G12 8TA, UK.

Malika Alimussina (M)

Developmental Endocrinology Research Group, School of Medicine, Dentistry and Nursing, University of Glasgow, Royal Hospital for Children, 1345 Govan Road, Glasgow G45 8TF, UK.

Stuart O'Toole (S)

Department of Pediatric Surgery, Royal Hospital for Children, 1345 Govan Road, Glasgow G45 8TF, UK.

Martyn Flett (M)

Department of Pediatric Surgery, Royal Hospital for Children, 1345 Govan Road, Glasgow G45 8TF, UK.

Boma Lee (B)

Department of Pediatric Surgery, Royal Hospital for Children, 1345 Govan Road, Glasgow G45 8TF, UK.

S Basith Amjad (SB)

Department of Pediatric Surgery, Royal Hospital for Children, 1345 Govan Road, Glasgow G45 8TF, UK.

Mairi Steven (M)

Department of Pediatric Surgery, Royal Hospital for Children, 1345 Govan Road, Glasgow G45 8TF, UK.

Katriona Brooksbank (K)

Institute of Cardiovascular and Medical Sciences, British Heart Foundation Centre for Research Excellence, University of Glasgow, 126 University Avenue, Glasgow G12 8TA, UK.

Linsay McCallum (L)

Institute of Cardiovascular and Medical Sciences, British Heart Foundation Centre for Research Excellence, University of Glasgow, 126 University Avenue, Glasgow G12 8TA, UK.

Christian Delles (C)

Institute of Cardiovascular and Medical Sciences, British Heart Foundation Centre for Research Excellence, University of Glasgow, 126 University Avenue, Glasgow G12 8TA, UK.

Sandosh Padmanabhan (S)

Institute of Cardiovascular and Medical Sciences, British Heart Foundation Centre for Research Excellence, University of Glasgow, 126 University Avenue, Glasgow G12 8TA, UK.

S Faisal Ahmed (SF)

Developmental Endocrinology Research Group, School of Medicine, Dentistry and Nursing, University of Glasgow, Royal Hospital for Children, 1345 Govan Road, Glasgow G45 8TF, UK.

Rhian M Touyz (RM)

Institute of Cardiovascular and Medical Sciences, British Heart Foundation Centre for Research Excellence, University of Glasgow, 126 University Avenue, Glasgow G12 8TA, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH